About Mitochondrial DNA-related progressive external ophthalmoplegia
Mitochondrial DNA-related progressive external ophthalmoplegia is a rare disease catalogued by Orphanet (ORPHA:663). It is associated with the MT-TS1, MT-TL2, MT-TN genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial DNA-related progressive external ophthalmoplegia trials.
Search ClinicalTrials.gov for "Mitochondrial DNA-related progressive external ophthalmoplegia" or filter by Orphanet code ORPHA:663 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial DNA-related progressive external ophthalmoplegia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial DNA-related progressive external ophthalmoplegia. Updated daily.